TR201900204A2 - İnhalasyon yolu i̇le pi̇rfeni̇don uygulanmasi - Google Patents

İnhalasyon yolu i̇le pi̇rfeni̇don uygulanmasi Download PDF

Info

Publication number
TR201900204A2
TR201900204A2 TR2019/00204A TR201900204A TR201900204A2 TR 201900204 A2 TR201900204 A2 TR 201900204A2 TR 2019/00204 A TR2019/00204 A TR 2019/00204A TR 201900204 A TR201900204 A TR 201900204A TR 201900204 A2 TR201900204 A2 TR 201900204A2
Authority
TR
Turkey
Prior art keywords
pirfenidone
pirphenidon
inhalation
application
drift
Prior art date
Application number
TR2019/00204A
Other languages
English (en)
Inventor
Ünlü Serdar
Şahi̇n Yasemi̇n
Orhan Uludağ Meci̇t
Ünlü Serkan
Farsali̇nos Konstanti̇nos
Original Assignee
Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2019/00204A priority Critical patent/TR201900204A2/tr
Publication of TR201900204A2 publication Critical patent/TR201900204A2/tr
Priority to EP19908233.0A priority patent/EP3883628A4/en
Priority to PCT/TR2019/051127 priority patent/WO2020145924A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bu buluş elektronik nikotin dağıtım sistemleri aracılığıyla pirfenidon?un pirfenidon çözeltisinden sürüklenme yolu ile uygulanması ve bu yol ile uygulanan pirfenidon?un idiopatik pulmoner fibrozis tedavisinde kullanımına ilişkindir.
TR2019/00204A 2019-01-08 2019-01-08 İnhalasyon yolu i̇le pi̇rfeni̇don uygulanmasi TR201900204A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2019/00204A TR201900204A2 (tr) 2019-01-08 2019-01-08 İnhalasyon yolu i̇le pi̇rfeni̇don uygulanmasi
EP19908233.0A EP3883628A4 (en) 2019-01-08 2019-12-19 USE OF PIRFENIDONE BY INHALATION
PCT/TR2019/051127 WO2020145924A1 (en) 2019-01-08 2019-12-19 Application of pirfenidone via inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/00204A TR201900204A2 (tr) 2019-01-08 2019-01-08 İnhalasyon yolu i̇le pi̇rfeni̇don uygulanmasi

Publications (1)

Publication Number Publication Date
TR201900204A2 true TR201900204A2 (tr) 2019-02-21

Family

ID=67955558

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/00204A TR201900204A2 (tr) 2019-01-08 2019-01-08 İnhalasyon yolu i̇le pi̇rfeni̇don uygulanmasi

Country Status (3)

Country Link
EP (1) EP3883628A4 (tr)
TR (1) TR201900204A2 (tr)
WO (1) WO2020145924A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230390274A1 (en) * 2020-10-15 2023-12-07 Epirium Bio Inc. Inhaled formulations of pgdh inhibitors and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104955508A (zh) * 2012-11-28 2015-09-30 艾尼科提恩科技公司 用于化合物递送的方法和设备
US10034988B2 (en) * 2012-11-28 2018-07-31 Fontem Holdings I B.V. Methods and devices for compound delivery
JP7066321B2 (ja) * 2014-01-10 2022-05-13 アヴァリン ファーマ インク． エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
PT3220987T (pt) * 2014-11-17 2019-08-27 Mcneil Ab Sistema eletrónico de dispensa de nicotina

Also Published As

Publication number Publication date
WO2020145924A1 (en) 2020-07-16
EP3883628A4 (en) 2022-02-09
EP3883628A1 (en) 2021-09-29

Similar Documents

Publication Publication Date Title
MY184586A (en) Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
EA202090932A1 (ru) Способы введения некоторых vmat2-ингибиторов
EA201892327A1 (ru) Ингаляционные и назальные бензодиазепины
MX2019006938A (es) Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon.
EA201990425A1 (ru) Спиролактамовые и бис-спиролактамовые модуляторы nmda-рецептора и их применение
EA201792591A1 (ru) Фармацевтические препараты
PH12020551018A1 (en) Oral delivery of glp-1 peptide analogs
CO2021013677A2 (es) Proceso para la fabricación de extractos bacterianos estables y su uso como fármacos
MX2018010032A (es) Formulaciones de antagonista de il-6 y sus usos.
PH12021550705A1 (en) Stable semaglutide compositions and uses thereof
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
BR112017023425A2 (pt) combinações terapêuticas de terapias antivirais e anti-inflamatórias
TR201900204A2 (tr) İnhalasyon yolu i̇le pi̇rfeni̇don uygulanmasi
MX2018006269A (es) Anticuerpo anti-alfa-v-integrina para el tratamiento de fibrosis y/o trastornos fibroticos.
PH12018500300A1 (en) Combination treatment comprising administration of 2-amino-3,5,5-trifluoro-3,4,5,6-tetradropyridines
EA202192322A1 (ru) Фармацевтические составы
EA201591415A1 (ru) Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии
EA201892842A1 (ru) Фармацевтические композиции, включающие сафинамид
EA201991531A1 (ru) Способы лечения композициями линаклотида с отсроченным высвобождением
EA201991817A1 (ru) Интраназальная композиция, включающая бетагистин
EA201890789A1 (ru) Содержащая цинеол композиция для лечения заболеваний носа
EA201990834A1 (ru) Пиримидиновые пролекарства для лечения вирусных инфекций и других заболеваний
EA202091127A1 (ru) Фармацевтические композиции, включающие сафинамид
EA202191327A1 (ru) Лекарственные формы терапевтических препаратов от гриппа
EA202090234A1 (ru) СРЕДСТВА РНКи ДЛЯ ИНГИБИРОВАНИЯ ЭКСПРЕССИИ АЛЬФА-ENaC И СПОСОБЫ ПРИМЕНЕНИЯ